Champoux Jennifer
Chief Operating Officer · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 4,351 | $23.38 | $101,729.86 | filing |
| 2026-07-15 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 4,351 | $3.98 | $17,316.98 | filing |
| 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 2,175 | $20.00 | $43,500.00 | filing |
| 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 2,175 | $3.98 | $8,656.50 | filing |
| 2026-06-17 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 2,176 | $19.00 | $41,344.00 | filing |
| 2026-06-17 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 2,176 | $3.98 | $8,660.48 | filing |
| 2026-05-27 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 2,175 | $20.00 | $43,500.00 | filing |
| 2026-05-27 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 2,175 | $3.98 | $8,656.50 | filing |
| 2026-05-22 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 2,176 | $19.00 | $41,344.00 | filing |
| 2026-05-22 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 2,176 | $3.98 | $8,660.48 | filing |
| 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 2,629 | $15.17 | $39,881.93 | filing |
| 2026-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Award | 35,000 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.